LPAR3 产品
(Lysophosphatidic Acid Receptor 3 (LPAR3))
Categories
antibodies-online.com stands for high-quality research products. Search, find and order tools with extensive validation data, images, references. Our scientific customer service is always at your disposal if you have any questions about the selection or application of our products.
Featured LPAR3 Categories
LPAR3 抗体
High quality antibodies with extensive validation data.
LPAR3 ELISA试剂盒
Reliable ELISA kits for a wide range of species.
LPAR3 蛋白
Proteins for various applications incl. WB, ELISA, IF etc.
Recommended LPAR3 抗体
- (4)
- (3)
- (1)
- (1)
Recommended LPAR3 ELISA试剂盒
- (1)
- (1)
- (1)
Recommended LPAR3 蛋白
- (1)
Latest Publications for our LPAR3 Products
: "Lysophosphatidic acid directly induces macrophage-derived foam cell formation by blocking the expression of SRBI." in: Biochemical and biophysical research communications, Vol. 491, Issue 3, pp. 587-594, (2017) (PubMed).: "Lysophosphatidic Acid Receptor Antagonism Protects against Diabetic Nephropathy in a Type 2 Diabetic Model." in: Journal of the American Society of Nephrology : JASN, Vol. 28, Issue 11, pp. 3300-3311, (2017) (PubMed).
: "LPA Induces Colon Cancer Cell Proliferation through a Cooperation between the ROCK and STAT-3 Pathways." in: PLoS ONE, Vol. 10, Issue 9, pp. e0139094, (2015) (PubMed).
: "LPA signaling through LPA receptors regulates cellular functions of endothelial cells treated with anticancer drugs." in: Molecular and cellular biochemistry, Vol. 408, Issue 1-2, pp. 147-54, (2015) (PubMed).
: "Different induction of LPA receptors by chemical liver carcinogens regulates cellular functions of liver epithelial WB-F344 cells." in: Molecular carcinogenesis, Vol. 55, Issue 11, pp. 1573-1583, (2015) (PubMed).
: "Expression of lysophosphatidic acid receptors and vascular endothelial growth factor mediating lysophosphatidic acid in the development of human ovarian cancer." in: Cancer letters, Vol. 192, Issue 2, pp. 161-9, (2003) (PubMed).
: "Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostate." in: Molecular pharmacology, Vol. 57, Issue 4, pp. 753-9, (2000) (PubMed).
: "Identification of an EDG7 variant, HOFNH30, a G-protein-coupled receptor for lysophosphatidic acid." in: Biochemical and biophysical research communications, Vol. 273, Issue 3, pp. 805-10, (2000) (PubMed).
Synonyms and alternative names related to LPAR3
lysophosphatidic acid receptor 3 (LPAR3), lysophosphatidic acid receptor 3 (LOC100038016), lysophosphatidic acid receptor 3 (Lpar3), Edg-7, EDG7, Edg7, GPCR, HOFNH30, LP-A3, LPA3, lpA3, RP4-678I3Protein level used designations for LPAR3
- endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 7
- lysophosphatidic acid receptor 3
- LPA receptor 3
- LPA receptor EDG7
- LPA-3
- calcium-mobilizing lysophosphatidic acid receptor LP-A3
- endothelial cell differentiation gene 7
- lysophosphatidic acid receptor Edg-7
- endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor 7
- putative G protein-coupled receptor snGPCR32
- snGPCR32